Novo Nordisk | NVO - Trade Creditors


Novo Nordisk reported DKK4.46B in Trade Creditors for its fiscal quarter ending in June of 2025.





Trade Creditors Change Date
ANI Pharmaceuticals USD 69.69M 7.11M Mar/2026
Aurora Cannabis CAD 9.31M 58.72M Mar/2026
Bausch Health Companies USD 593M 7M Mar/2026
Bristol-Myers Squibb USD 4.23B 659M Mar/2026
Canopy Growth CAD 34.82M 14.85M Mar/2026
Corcept Therapeutics USD 33.31M 7.14M Mar/2026
Drreddys Laboratories INR 22.36B 21.91B Mar/2026
Eli Lilly USD 5.03B 350M Mar/2026
GlaxoSmithKline GBP 14.34B 1.05B Mar/2026
Merck USD 3.86B 541M Mar/2026
Nektar Therapeutics USD 10.77M 4.79M Dec/2025
Novartis USD 4.32B 134M Mar/2026
Novo Nordisk DKK 14.8B 4.96B Mar/2026
Novo Nordisk DKK 4.46B 15.12B Jun/2025
Pacira USD 14.01M 1.14M Mar/2026
Perrigo USD 434.8M 39.7M Mar/2026
Phibro Animal Health USD 129.64M 3.65M Mar/2026
Prestige Brands USD 22.79M 20.15M Mar/2026
Sanofi EUR 22.71B 219M Mar/2026
Supernus Pharmaceuticals USD 10.17M 97.63M Mar/2026
Zoetis USD 507M 20M Mar/2026